The National Multiple Sclerosis Society has revealed its support for four innovative multiple sclerosis (MS) research initiatives as part of its latest Research Grant Programme cycle. Additionally, this launch marks the beginning of a new grant cycle dedicated to enhancing MS research efforts in the UAE.
This new cycle attracted significant engagement from researchers nationwide, receiving 36 letters of intent and 34 comprehensive project applications. After careful evaluation, four projects have been chosen for funding, highlighting the increasing dedication to MS research within the UAE.
The upcoming grant cycle focuses on the theme “Advancing MS Innovation through Autoimmune Discovery,” aimed at deepening the understanding of MS through various aspects such as immunobiology, environmental and genetic risk factors, emerging treatments, and precision medicine tailored to enhance patient healthcare.
Her Excellency Dr. Fatima Al Kaabi, Vice Chair of NMSS, praised the funded projects, noting the UAE's evolving research landscape, particularly in the realms of artificial intelligence and precision medicine. She believes that local research will significantly enhance treatment outcomes for those affected by MS while enriching global knowledge.
Highlighted Research Initiatives
One notable project led by Dr. Bassem Yamout at Harley Street Medical Center focuses on utilizing artificial intelligence (AI) to refine MRI accuracy. This initiative aims to improve differentiation between MS and neuromyelitis optica spectrum disorder, thus minimizing misdiagnoses and enabling timely treatment interventions.
Another research endeavor by Dr. Omer Alkhnbashi at Mohammed Bin Rashid University of Medicine and Health Sciences is working on a predictive AI tool. This tool integrates clinical, imaging, and genetic data to determine optimal treatment strategies for MS patients in the UAE.
At New York University Abu Dhabi, Dr. Youssef Idaghdour leads the HEAL MS study, which investigates how lifestyle adjustments—such as improved nutrition, physical activity, and stress management—can affect biological markers and enhance the overall wellness of MS patients.
Dr. Nemat Ullah Khan from Khalifa University is researching a potential neuroprotective agent named Hi1a, derived from the venom of the Australian funnel-web spider. This study utilizes brain organoids to study nerve protection and potential myelin restoration.
Funding Overview and Future Initiatives
Since its inception in June 2023, the NMSS Research Grants Programme has invested approximately AED 11 million into MS-focused research. These initiatives aim at developing new therapies, understanding the disease, assessing its prevalence in the UAE, and conducting genetic studies.
In preparation for the fourth cycle, researchers are invited to submit letters of intent from June 1 to July 5, 2026, followed by full proposals due by August 23, 2026. Final funding outcomes will be communicated in December 2026.
A 9th-grade student in Tripura faces detention after alleged assault on a six-year-old neighbor in K
Toshifumi Suzuki, the founder of 7-Eleven Japan and a pioneer in convenience retail, has died at the
A nine-story construction project collapsed in Angeles City, leaving 21 individuals unaccounted for
Bahrain's court has sentenced nine individuals to life, citing connections to Iran's IRGC, raising f
